USP32 and hepatocellular carcinoma: Due to the fact that Huh7 and HCC-LM3 cells carry different TP53 mutants, further studies could use HCC cell lines expressing wild-type p53 to eliminate the potential effect of TP53 status on USP32 overexpression-induced cell proliferation.